Péter Ferdinandy, MD, PhD, MBA, Founder & CEO of Pharmahungary Group has been noticed as “Highly Cited Researcher” for the 4th time.
Further information here.
The main purpose of HBA is to strengthen the position of biotechnology as a strategic industry in Hungary.
In each year HBA organizes special forums which provide opportunities for personal contacts between researchers, investors, companies and government decision-makers.
The forum will continue to bring together the academic, business and public sectors in order to create more efficient and more successful collaborations not only at a national, but also at an international level.